Microbiome and women's health (literature review)


  • Д. С. Янковский Science production company “O.D. Prolisok”, Kyiv, Ukraine
  • В. П. Широбоков National Medical University named after o.o. Bogomolets, Ukraine
  • Ю. Г. Антипкин Institute of pediatrics, obstetrics and gynecology of the NAM S of Ukraine Association of Pediatricians of Ukraine, Ukraine
  • Т. Ф. Татарчук Institute of Pediatrics, Obstetrics and Gynecology of the NAM S of Ukraine, Ukraine
  • Г. С. Дымент SPC “O.D. Prolisok”, Kyiv, Ukraine




microbiome, biofilm, microbial communities, probiotics, chelators, Symbiter®, Smectovit®


In recent decades increased interest in natural microbiome - microbial communities colonizing the mucous membranes and skin of human. Microbiome is involved in metabolic and genetic regulatory mechanisms of human life, and also creates a powerful defense of microorganism from colonizing alien microorganisms. Mouth, upper respiratory tract, gastrointestinal and urogenital tract, skin are populated by different types of microorganisms.

It was found that the breach of the vaginal microbiome associated with the development of bacterial vaginosis, nonspecific (aerobic), vaginitis and mycotic vaginitis. Numerous studies have confirmed the effectiveness of probiotic therapy in the treatment of patients with various forms of urological and obstetrical and gynecological pathology, aimed at restoring the natural microbiome.

Author Biographies

Д. С. Янковский, Science production company “O.D. Prolisok”, Kyiv

MD, professor, general director

В. П. Широбоков, National Medical University named after o.o. Bogomolets

MD, professor, academician of the NAS of Ukraine, academician of the NAM S of Ukraine, head of the Microbiology, Immunology and Virology Department

Ю. Г. Антипкин, Institute of pediatrics, obstetrics and gynecology of the NAM S of Ukraine Association of Pediatricians of Ukraine

MD, professor, academician of the NAM S of Ukraine, director;


Т. Ф. Татарчук, Institute of Pediatrics, Obstetrics and Gynecology of the NAM S of Ukraine

MD, professor, corresponding member of the NAM S of Ukraine, Deputy Director for Research Work, Chief of the Endocrine Gynecology Department

Г. С. Дымент, SPC “O.D. Prolisok”, Kyiv

PhD, director of the science centre 


  1. Ankirskaya, A.S. “Bacterial vaginosis.” Obstetrics and Gynecology, 3(2005): 10–13.
  2. Bondarenko, V.M., Rubakova, E.I., Lavrova, V.A. “Immunostimulatory effects of lactic acid bacteria that are used as the basis for preparations of probiotics.” Microbiology, Epidemiology and Immunology Journal, 5(1998): 107–112.
  3. Cherkasov, S.V. “Characteristics of the vaginal microflora in intrauterine contraception.” Microbiology, Epidemiology and Immunology Journal, 4(1999): 63–65.
  4. Ventskovsky, B.M., Tovstanovskaya, V.A., Gutsulyak, R.V., et al. The use of probiotics in the treatment of and prevention of inflammatory diseases in obstetrics and gynecology: Method. Recommendation. Kyiv (2001): 28 p.
  5. Voropaeva, E.A., Afanasyev, S.S., Aleshkin, V.A., Vorobyov, A.A., et al. “Microbiological and immunological characteristics dysbiotic habitat violations of the mucous membranes of the respiratory and urogenital tracts.” Herald of the Russian AM S, 1(2006): 3–5.
  6. Ginzburg, A.L., Ilyina, T.S., Romanova, Y.M. “"Quorum sensing" or social lives of bacteria.” Microbiology, Epidemiology and Immunology Journal, 5(2003): 86–93.
  7. Gusak, Y.K., Morozov, V.N., Chikin, V.G., Darmogray, V.N. “Role of the enterosorption in treatment of placental dysfunction.” Collection of works on the use of the drug “Enterosgel” in medicine. Moscow (2002): 50–57.
  8. Ilyenko, L.H., Ivanova, E.V. “Evaluating the effectiveness of the sorbent "Enterosgel" in the complex treatment of relapsing forms of vaginal candidiasis.” Collection of works on the use of the drug "Enterosgel" in medicine. Moscow (2002): 26–34.
  9. Kira, E.F. “Infections and Reproductive Health.” Journal of Obstetrics and Gynecological Diseases, Issue 2 (Vol. XVII) (1999):71–78.
  10. Kira, E.F., Berlev, I.V., Molchanov, O.L. “Features of pregnancy, childbirth and the postpartum period in women with vaginal dysbiotic disorders.” Journal of Obstetrics and Gynecological Diseases, Issue 2 (Vol. XLVII) (1999): 8–11.
  11. Kira, E.F. “Probiotics in gynecological practice.” Journal ROA G, 3(2008): 6–11.
  12. Kira, E.F. Bacterial vaginosis. Moscow. MIA (2012): 472 p.
  13. Kotibenko, E.N. “Optimizing treatment of urogenital infections in pregnant women with sorbents.” Thesis abstract on the degree of PhD, Obstetrician and Gynecology, Moscow State University of Medicine and Dentistry. Moscow (2000): 24 p.
  14. Korshunov, V.M., Volodin, N.N., Efimov, B.A., et al. Vaginal Microecology. Correction of vaginal microflora dysbiosis. Tutorial. Moscow (1999): 79 p.
  15. Kravchenko, O.V., Gutsuliak, R.V., Yankovskyi, D.S. “Probiotic "Symbiter" in the treatment of bacterial vaginosis.” Pediatrics, Obstetrics and Gynecology, 5(2002): 100–102.
  16. Martikaynen, Z.M., Derkach, O.I., Golovacheva, S.N., et al. “Formation of vaginal microbiocenosis at postpartum using different eubiotic drugs.” Journal of Obstetrics and Gynecological Diseases, 2 (Vol. ХLХ) (2001): 58–61.
  17. Ott, V.D., Marushko, T.L., Tutchenko, L.I., Mukvich, A.M. “Systemic microbiota disorders, their prevention and treatment with multicomponent probiotics in pregnant women, breastfeeding mothers and children.” Materials of International Scientific and Practical Conference “Probiotics of XXI century. Biology. Medicine. Practice.”. Ternopil (2004): 127–132.
  18. Plotko, E.E., Donnikov, A.E., Voroshilina, E.S., Hayutin, L.V., Tumbinskaya, L.V. “Vaginal biocenosis from point of PCR view: what is the norm?” Obstetrics and Gynecology, 1(2011): 66–70.
  19. Savitskaya, K.I., Vorobyov, A.A., Molochkov, V.A., Zur, N.V. “The normal flora of the genital tract of healthy women of reproductive age.” Herald of Russian AM S, 9(2003): 48–52.
  20. Titova, S.I., Goncharova, N.G. “Evaluation of the clinical efficacy, safety and tolerability of the combination of prebiotic and enterosorbent in therapy of bacterial vaginosis.” Attending Physician, 10(2008): 74–76.
  21. Tutchenko, L.I., Ott, V.D., Marushko, T.L., et al. “Features of formation system microbiota in neonates and infants and ways to optimize.” Journal of Practical Doctor, 5(2001): 24–30.
  22. Shyrobokov, V.P., Yankovskyi, D.S., Dyment, H.S. “New strategies in the development and clinical use of probiotics.” Pharmacology and Pharmacy Herald, 2(2010): 18–30.
  23. Shyrobokov, V.P., Yankovskyi, D.S., Dyment, H.S. The microbes in biogeochemical processes, the evolution of the biosphere and the existence of mankind. Kyiv. SP Veres O.I. (2014): 464 p.
  24. Yankovskyi, D.S., Dyment, H.S. Microflora and human health. Kyiv. “Red Ruta-Tours” LLC (2008): 552 p.
  25. Yankovskyi, D.S., Dyment, H.S. “Improving women's reproductive health by optimizing microecology of digestive and urogenital tract.” Reproductive Women's Health, 3(2007): 148–154.
  26. Yankovskyi, D.S., Dyment, H.S. “The use of probiotics to improve the reproductive health of women.” Women's Health, 2(34) (2008): 161–170.
  27. Yankovskyi, D.S., Moiseenko, R.A., Dyment, H.S. “Dysbiosis place in human pathology.” Contemporary Pediatrics, 1(29) (2010): 154–167.
  28. Yankovskyi, D.S., Shyrobokov, V.P., Dyment, H.S. An integral part of the symbiotic microflora in human physiology. Kyiv. “Red Ruta-Tours” LLC (2011): 169 p.
  29. Yankovskyi, D.S., Shyrobokov, V.P., Volosovets, A.P., Moiseenko, R.A., Dyment, H.S. “Human microbes and modern methods of its improvement.” Journal of the NAM SU (2014).
  30. Aagaard, K., Ma, J., Antony, K.M., Ganu, R., Petrosino, J., Versalovic, J. “The Placenta Harbors a Unique Microbiome.” Sci Transl Med, 6(2014): 237–265.
  31. Abad, C.L., Safdar, N. “The role of Lactobacillus probiotics in the treatment or prevention of urogenital infection – a systematic review.” J Chemother, 21(3) (2009): 243–252.
  32. Afrakhteh, M., Mahdavi, A. “Bacterial vaginosis and urinary tract infection.” J Obstet Gynecol India, 57(2007): 513–516.
  33. Anderson, B.L., Cu-Uvin, S., Raker, C.A., et al. “Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women.” Acta Obstet Gynecol Scand, 5 (Vol. 90) (2011): 510.
  34. Antonio, M.A., Hawes, S.E., Hillier, S.L. “The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species.” J Infect Dis, 180(6) (1999): 1950–1956.
  35. Anukam, K.C., Osazuwa, E.O., Ahonkhai, I., Reid, G. “16S rRNA gene sequence and phylogenetic tree of Lactobacillus species from the vagina of healthy Nigerian women.” African Journal of Biotechnology, 4(11) (2005): 1222–1227.
  36. Anukam, K., Osazuwa, E., Ahonkhai, I., Ngwu, M., Osemene, G., Bruce, A.W. “Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.” Microb Infect, 8(2006): 1450–1454.
  37. Aroutcheva, A., Gariti, D., Simon, M., Shott, S., Faro, J., Simoes, J.A. “Defense factors of vaginal lactobacilli.” Am J Obstet Gynecol, 185(2001): 375–379.
  38. Aroutcheva, A., Ling, Z., Faro, S. “Prevotella bivia as a source of lipopolysaccharide in the vagina.” Anaerobe, 14(5) (2008): 256–260.
  39. Arzeni, D., Del Poeta, M., Simonetti, O., Offidani, A.M., Lamura, L., et al. “Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.” Eur J Epidemiol, 13(4) (1997): 447–450.
  40. Aruna, K., Jyoti, K. “Role of bacterial vaginosis in preterm labor.” J Obstet Gynecol India, 57(2007): 413–416.
  41. Barrons, R., Tassone, D. “Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.” Clin Ther, 30(3) (2008): 453–468.
  42. Bodean, O., Munteanu, O., Cirstoiu, C., et al. “Probiotics a helpful additional therapy for bacterial vaginosis.” J Med Life, 4 (Vol. 6) (2013): 434–436.
  43. Bradshaw, C.S., Tabrizi, S.N., Fairley, C.K. “The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.” J Infect Dis, 194(2006): 828–836.
  44. Bruce, A.W., Reid, G. “Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections.” Can J Microbiol, 34(1988): 339–343.
  45. Burton, J.P., Cadieux, P.A., Reid, G. “Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation.” Appl Environ Microbiol, 69(2003): 97–101.
  46. Cadieux, P., Burton, J.C., Gardiner, I. “Lactobacillus strains and vaginal ecology.” JAMA , 287(2002): 1940–2041.
  47. Cauci, S., Monte, R., Driussi, S. “Impairment of the mucosal immune-system: IgA and IgM cleavage detected in vaginal washings of subgroup of patients with bacterial vaginosis.” J Infect Dis, 6 (Vol. 178) (1998): 1698–1706.
  48. Christensen, J. “Bacterial vaginosis and cervical intraepithelial neoplasia. Obstetrics Gynecology Scandinavia, 73(1994): 586–588.
  49. Colodner, R., Edelstein, H., Chazan, B., Raz, R. “Vaginal colonization by orally administered Lactobacillus rhamnosus GG.” Isr Med Assoc J, 5(2003): 767–769.
  50. Corrigan, E.M., Clancy, R.L., Dunkley, M.L., Eyers, F.M., Beagley, K.W. “Cellular immunity in recurrent vulvovaginal candidiasis.” Clin Exp Immunol, 111(3) (1998): 574–578.
  51. Delia, A., Morgante, G., Rago, G., Musacchio, M.C., Petraglia, F., De Leo, V. “Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidophilus in the treatment of vaginosis and in the prevention of recurrent vaginitis.” Minerva Ginecol, 58(2006): 227–231.
  52. Di Giulio, D.B., Romero, R., Amogan, H.P., Kusanovic, J.P., Bik, E.M., et al. “Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation.” PLoS ONE, 3(2008): e3056.
  53. Donders, G.G., Vereecken, A., Bosmans, E., et al. “Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis.” BJOG, 1 (Vol. 109) (2002): 34–43.
  54. Donders, G., Bellen, G., Ausma, J., Verguts, L., Vaneldere, J., Hinoul, P., et al. “The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.” Eur J Clin Microbiol Infect Dis, 30(2011): 59–63.
  55. Dover, S.E., Aroutcheva, A.A., Faro, S., Chikindas, M.L. “Natural antimicrobials and their role in vaginal health: A short review.” Int J Probiotics Prebiotics, 3(2008): 219–230.
  56. Edlund, C., Nord, C.E. “Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infection.” J Antimicrob Chemoter, 46(2000): 41.
  57. Ehrström, S., Daroczy, K., Rylander, E., Samuelsson, C., et al. “Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.” Microbes Infect, 12(2010): 691–699.
  58. Eriksson, K.L., Carlsson, B., Forsum, U., et al. “A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal: clindamycin ovules.” Acta Derm Venereol, 1 (Vol. 85) (2005): 42–46.
  59. Eschenbach, D.A., Thwin, S.S., Patton, D.L., Hooton, T.M., et al. “Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora.” Clin Infect Dis, 30(2000): 901–917.
  60. Eschenback, D.A., Hiller, S.L. “Diagnosis and clinical manifestation of bacterial vaginosis.” Am J Obstet Gynecol, 158(2002): 819–828.
  61. Falagas, M.E., Betsi, G.I., Tokas, T., Athanasiou, S. “Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.” Drugs, 66(9) (2006): 1253-1261.
  62. Farage, M., Maibach, H. “Lifetime changes in the vulva and vagina.” Arch Gynecol Obstet, 273(2006): 195–202.
  63. Farage, M., Bramante, M., Otaka, Y., Sobel, J. “Do panty liners promote vulvovaginal candidiasis or urinary tract infections? A review of the scientific evidence.” Eur J Obstet Gynecol Reproduct Biol, 132(2007): 8–19.
  64. Fortner, K.B., Grotegut, C.A., Ransom, C.E., Bentley, R.C., Feng, L., et al. “Bacteria localization and chorion thinning among preterm premature rupture of membranes.” PLoS One, 9(1) (2014): 8.
  65. Fredricks, D.N., Fiedler, T.L., Marrazzo, J.M. “Molecular identification of bacteria associated with bacterial vaginosis.” N Engl J Med, 353(2005): 1899–1911.
  66. Fredricks, D.N., Fiedler, T.L., Thomas, K.K., Oakley, B.B., Marrazzo, J.M. “Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.” J Clin Microbiol, 45(2007): 3270–3276.
  67. Fuqua, W.C., Winans, S.C., Greenberg, E.P. “Quorum sensing in bacteria: the LuxR – LuxI family of cell density-responsive transcriptional regulators.” J Bacteriol, 176(2) (1994): 269–275.
  68. Gelber, S.E., Aquilar, J.L., Lewis, K.L.T., Rather, A.J. “Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerella vaginalis.” J Bacteriol, 190(2008): 3896–3903.
  69. Gillet, E., Meys, J.F., Verstraelen, H., Verhelst, R., De Sutter, P., et al. “Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and metaanalysis.” PLoS One, 7(10) (2012): e45201.
  70. Hillier, S. “The complexity of microbial diversity in bacterial vaginosis.” N Eng J Med, 353 (2005): 1886–1887.
  71. Hoesl, C.E., Altwein, J.E. “The probiotic approach: an alternative treatment option in urology.” Eur Urol, 47(2005): 288–296.
  72. Homayouni, A., Bastani, P., Ziyadi, S., et al. “Effects of probiotics on the recurrence of bacterial vaginosis: a review.” J Low Genit Tract Dis, 18(1) (2014): 79–86.
  73. Hummelen, R., Changalucha, J., Butamanya, N.L., et al. “Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.” Int J Gynecol Obstet, 111(2010): 245–248.
  74. Klebanoff, M.A., Nansel, T.R., Brotman, R.M., Zhang, J., et al. “Personal hygienic behaviors and bacterial vaginosis.” Sex Transm Dis, 37(2010): 94–99.
  75. Krauss-Silva, L., Moreira, M.E., Alves, M.B., et al. “Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol.” Reproductive health, 7(2010): 14.
  76. Lamont, R.F., Sobel, J.D., Akins, R.A., Hassan, S.S., et al. “The vaginal microbiome: new information about genital tract flora using molecular based techniques.” BJOG, 118(5) (2011): 533.
  77. Lechtovirta, P. “Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.” Int Journal STD AIDS, 1(2008): 37–41.
  78. Lederberg, J., McCray, A.T. “'Ome sweet 'omics - A genealogical treasury of words.” Scientist, 15(7) (2001): 8.
  79. Leitich, H., Bodner-Adler, B., Brunbauer, M., et al. “Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis.” Am J Obstet Gynecol, 189(2003): 139–147.
  80. Lepargneur, J.P., Rousseau, V. “Protective role of the Doderlein flora.” J Gynecol Obstet Biol Reprod (Paris), 31(2002): 485–494.
  81. Leung, K.W., Barnstable, C.J., Tombran-Tink, J. “Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signalling.” Molecular Immunology, 46(2009): 1374–1386.
  82. Linhares, I.M., Giraldo, P.C., Baracat, E.C. “New findings about vaginal bacterial flora.” Revista da Associacao Medica Brasileira, 3 (Vol. 56) (2010): 370–374.
  83. Machado, A., Jefferson, K., Cerca, N. “Interaction between Lactobacillus crispatus and BV-associated bacterial species in initial attachment and biofilm formation.” Int J Mol Sci, 14(6) (2013): 12004–12012.
  84. Malazy, O.T., Shariat, M., Heshmat, R., Majlesi, F., et al. “Vulvovaginal candidiasis and its related factors in diabetic women.” Taiwan J Obstet Gynecol, 46(4) (2007): 399–404.
  85. Marcone, V., Rocca, G., Lichtner, M., Calzolari, E. “Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis.” Int J Gynecol Obstet, 110(2010): 223–226.
  86. Mastromarino, P., Vitali, B., Mosca, L. “Bacterial vaginosis: a review on clinical trials with probiotics.” New Microbiol. 36(3) (2013): 229–238.
  87. Mastromarino, P., Di Pietro, M., Schiavoni, G., Nardis, C., Gentile, M., Sessa, R. “Effects of vaginal lactobacilli in Chlamydia trachomatis infection.” International Journal of Medical Microbiology, 5–6 (Vol. 304) (2014): 654–661.
  88. Matu, M.N., Orinda G.O., Njagi, E.N., Cohen, C.R., Bukusi, E.A. “In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women.” Anaerobe, 16(2010): 210–215.
  89. McLean, N.W., Rosenstein, I.J. “Characterization and selestion of a Lactobacillus species to recolonize the vagina of women with recurrent bacterial vaginosis.” J Med Microbiol, 4 (Vol. 49) (2000): 543–552.
  90. McMillan, A., Dell, M., Zellar, M.P., Cribby, S., Martz, S., Hong, E., et al. “Disruption of urogenital biofilms by lactobacilli.” Colloids Surf B Biointerfaces, 86(2011): 58–64.
  91. Miller, L., Thomas, K., Hughes, J.P. “Randomised treatment trial of bacterial vaginosis to prevent post-abortion complication.” BJOG, 9 (Vol/ 11) (2004): 982–988.
  92. Mirmonsef, P., Gilbert, D., Veazey, R.S., Wang, J., Kendrick, S.R., Spear, G.T. “A comparison of lower genital tract glycogen and lactic acid levels in women and macaques: Implications for HIV and SIV susceptibility.” AIDS Res Hum Retroviruses, 28(2012): 76–81.
  93. Money, D. “The laboratory diagnosis of bacterial vaginosis.” Can J Infect Dis Med Microbiol, 16(2005): 77–79.
  94. Morelli, L., Zonenenschain, D., Del Piano, M., et al. “Utilization of the intestinal tract as a delivery system for urogenital probiotics.” J Clin Gastroenterol, 38(6) (2004): 107–110.
  95. Neeser, J.R., Granato, D., Rouvet, M., Servin, A., et al. “Lactobacillus johnsonii La 1 shares carbohydrate-binding specificities with several enteropathogenic bacteria.” Glycobiology, 10(2000): 1193–1199.
  96. Orendi, J.M., Coetzee, N., Ellington, M.J., et al. “Community and nosocomial transmission of Panton-Valentine leucocidin-positive community-associated meticillin-resistant Staphylococcus aureus: implications for healthcare.” The Journal of hospital infection, 4 (Vol. 75) (2010): 258–264.
  97. Qin, J., Li, R., Raes, J., Arumugam, M., et al. “A human gut microbial gene catalogue established by metagenomic sequencing. MetaHIT Consortium.” Nature, 464(7285) (Vol. 4) (2010): 59–65.
  98. Patterson, J.L., Girerd, P.H., Karjane, N.W., Jefferson, K.K. “Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid.” Am J Obstet Gynecol, 197(2007): 170.
  99. Pirotta, M., Gunn, J., Chondros, P. “Effect of Lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomized controlled trial.” BMJ, 329(2004): 548.
  100. Prince, A.L., Antony, K.M., Chu, D.M., et al. “The microbiome, parturition, and timing of birth: more questions than answers.” J Reprod Immunol, 10(2014): 104–105.
  101. Ravel, J., Gajer, P., Abdo, Z., Schneider, G.M., Koenig, S.S., McCulle, S.L. “Vaginal microbiome of reproductive-age women.” Proc Natl Acad Sci USA, 108(2011): 4680–4687.
  102. Reid, G., Bruce, A.W., Fraser, N. “Oral probiotics can resolve urogenital infection.” FEMS Immunol Med Microbiol, 30(2001): 49–52.
  103. Reid, G., Burton, J. “Use of Lactobacillus to prevent infection by pathogenic bacteria.” Microbes Infect, 4(2002): 319–324.
  104. Reid, G., Bocking, A. “The potential for probiotics to prevent bacterial vaginosis and preterm labor.” Am J Obstet Gynecol, 189(2003): 1202–1208.
  105. Reid, G., Devillard, E. “Probiotics for mother and child.” J Clin Gastroenterol, 38(2004): 94–101.
  106. Roberts, C.L., Morris, J.M., Rickard, K.R., et al. “Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth.” BMC pregnancy and childbirth, 11(2011): 19.
  107. Rode, M.E., Morgan, M.A., Rucelli, E.A., et al. “Candida chorioamnionitis after serial therapeutic amniocenteses: a possible association.” J Perinatol, 20(5) (2000): 335–337.
  108. Ryckman, K.K., Simhan, H.N., Krohn, M.A., Williams, S.M. “Predicting risk of bacterial vaginosis: The role of race, smoking and corticotropin-releasing hormone-related genes.” Mol Hum Reprod, 15(2009): 131–137.
  109. Shi, Y., Chen, L., Tong, J., Xu, C. “Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation-independent methods.” J Obstet Gynaecol Res, 35(2009): 525–532.
  110. Sobel, J.D., Ferris, D., Schwebke, J., Nyirjesy, P., Wiesenfeld, H.C., et al. “Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.” Am J Obstet Gynecol, 194(2006): 1283–1289.
  111. Stoyancheva, G., Danova, S., Boudakov, I.Y. “Molecular identification of vaginal lactobacilli isolated from Bulgarian women.” Antonie Van Leeuwenhoek, 90(2006): 201–210.
  112. Srinivasan, U., Misra, D., Marazita, M.L., Foxman, B. “Vaginal and oral microbes, host genotype and preterm birth.” Med Hypotheses, 73(2009): 963–975.
  113. Srinivasan, U., Liu, C., Mitchell, C.M., Fiedler, T.L., Thomas, K.K., Agnew, K.J. “Temporal variability of human vaginal bacteria relationship with bacterial vaginosis.” PLoS One, 5(2010): e10197.
  114. Swidsinski, A., Mendling, W., Loening-Baucke, V., Ladnoff A., et al. “Adherent biofilms in bacterial vaginosis.” Obstet Gynecol, 106(2005): 1013–1023.
  115. Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., et al. “The human microbiome project.” Nature, 449(7164) (2007): 804–810.
  116. Vallor, A.C., Antonio, M.A., Hawes, S.E., Hiller, S.L. “Factors associated with acqusition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production.” J Infect Dis, 184(2001): 1431–1436.
  117. Vásquez, A., Jakobsson, T., Ahrné, S., Forsum, U., Molin, G. “Vaginal Lactobacillus flora of healthy Swedish women.” J Clin Microbiol, 40(2002): 2746–2749.
  118. Walther-Antonio, M., Jeraldo, P., Berg Miller, M.E., et al. “Pregnancy's Stronghold on the Vaginal Microbiome.” J List PLoS One, 9(6) (2014): e98514.
  119. Wilks, M., Wiggins, R., Whiley, A. “Identification and H2O2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome.” J Clin Microbiol, 42(2004): 13–17.
  120. Yamamoto, T., Zhou, X., Williams, C.J., Hochwalt, A., Forney, L.J. “Bacterial populations in the vaginas of healthy adolescent women.” J Pediatr Adolesc Gynecol, 22(2009): 11–18.
  121. Ya, W., Reifer, C., Miller, L.E. “Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: A double-blind, randomized, placebo-controlled study.” Am J Obstet Gynecol, 203(120) (2010): 1–6.
  122. Zhou, X., Bent, S.J., Schneider, M.G., Davis, C.C., Islam, M.R., Forney, L.J. “Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods.” Microbiology, 150(2004): 2565–2573.
  123. Zodzika, J., Rezeberga, D., Jermakova, I., et al. “Factors related to elevated vaginal pH in the first trimester of pregnancy.” Acta obstetricia et gynecologica Scandinavica, 1 (Vol. 90) (2011): 41–46.
  124. Zozaya-Hinchliffe, M., Lillis, R., Martin, D.H., Ferris, M.J. “Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis.” J Clin Microbiol, 48(5) (2010): 1812–1819.



How to Cite

Янковский, Д. С., Широбоков, В. П., Антипкин, Ю. Г., Татарчук, Т. Ф., & Дымент, Г. С. (2015). Microbiome and women’s health (literature review). REPRODUCTIVE ENDOCRINOLOGY, (24), 13–28. https://doi.org/10.18370/2309-4117.2015.24.13-28



Health care

Most read articles by the same author(s)

1 2 3 4 > >>